Table 1.
Current anti-TNF-α available treatments in non-infectious uveitis.
| Therapy | Description | Study type | References |
|---|---|---|---|
| Adalimumab | Anti TNF-α humanized antibody | Clinical trial | (Diaz-Llopis et al., 2008) |
| Systematic review | (Borrás-Blasco et al., 2015) | ||
| Clinical trial | (Jaffe et al., 2016) | ||
| Clinical trial | (Goto et al., 2019) | ||
| Prospective study | (Sharma et al., 2019) | ||
| Meta-analysis | (Leal et al., 2019) | ||
| Systematic review | (Leal et al., 2018) | ||
| Clinical trial | (Suhler et al., 2018) | ||
| Clinical trial | (Lee et al., 2018) | ||
| Retrospective study | (Mercier et al., 2018) | ||
| Clinical trial | (Nguyen et al., 2016) | ||
| Infliximab | Anti TNF-α chimeric antibody | Systematic review | (Borrás-Blasco et al., 2015) |
| Prospective study | (Sharma et al., 2019) | ||
| Meta-analysis | (Leal et al., 2019) | ||
| Systematic review | (Leal et al., 2018) | ||
| Retrospective study | (Mercier et al., 2018) | ||
| Golimumab | Anti TNF-α humanized antibody | Systematic review | (Borrás-Blasco et al., 2015) |
| Meta-analysis | (Leal et al., 2019) | ||
| Systematic review | (Leal et al., 2018) | ||
| Etanercept | Anti TNF-α dimeric protein, act as a decoy for TNF-α Receptor | Meta-analysis | (Leal et al., 2019) |
| Systematic review | (Leal et al., 2018) | ||
| Certolizumab | Anti TNF-α antibody | Systematic review | (Leal et al., 2019) |
| Systematic review | (Leal et al., 2018) |
TNF-α, tumor necrosis factor alpha.